BridgeBio Oncology Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $164.3M
Liabilities Breakdown FY2024
Total Liabilities: $19.6M
Asset Breakdown
Total Assets: $164.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $30.9M | 18.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $490.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $133.0M | 80.9% |
Liabilities Breakdown
Total Liabilities: $19.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 15.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.5M | 84.3% |